Company / AR per Share
Jazz Pharmaceuticals AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$13.70
FY2025
5-year range
$10.03 / $13.70
FY2021-FY2025
Trend
+19.0%
vs FY2024
Sector context
#5 of 115
Health Care
What the data says
Among 115 Health Care companies, Jazz Pharmaceuticals is in the top 4% for ar per share. AR per Share has increased for 8 consecutive years, from $3.75 in FY2017 to $13.70 in FY2025.
Based on SEC 10-K filings.
13.70 in FY2025 with a 5-year CAGR of +14.2%. Top quartile in the Health Care sector.
Improved from $11.17 to $13.70 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +9.0%
- 5-Year CAGR
- +14.2%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 115This company $13.70 Sector average $27.05
▼
-49.4% below sector average
Key checks
Key Insights
- Jazz Pharmaceuticals's ar per share has grown for 8 consecutive years.
- In FY2025, ar per share increased 19.0% year-over-year.
- Ranks #5 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.70 | +19.0% |
| FY2024 | $11.51 | +3.1% |
| FY2023 | $11.17 | +5.6% |
| FY2022 | $10.57 | +5.4% |
| FY2021 | $10.03 | +42.0% |
| FY2020 | $7.06 | +14.5% |
| FY2019 | $6.17 | +37.7% |
| FY2018 | $4.48 | +19.6% |
| FY2017 | $3.75 | -1.9% |
| FY2016 | $3.82 | +10.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026